Transcript Slide 1
Radhika Tandon, MD, DNB, FRCS, FRCOphth Dr. Manoj Sharma, MD Dr. Bhavna Chawla, MS Dr Namrata Sharma, MD Prof. Jeewan.S.Titiyal, MD Prof. Gita Satpathy, MD* Department of Cornea, Cataract & Refractive Surgery and *Ocular Microbiology Dr Rajendra Prasad Centre For Ophthalmic Sciences, AIIMS The authors have no financial interest in the subject matter of this poster. Table 1- Shedding of herpes simplex virus type 1 (HSV-1) DNA in active stromal keratitis and / or endotheliitis, as detected by polymerase chain reaction analysis of tear samples obtained from different method Subjects, proportion (%)* Sample method Total Sample collected per subject, no. - Schirmer’s 1 5/15(33.33%) - Schirmer’s 3.3 Pramod NP et al.(2000 ) [(Conventional PCR] 12/40(30%) - Schirmer’s 2 Fukuda M et. al (2003) [Real-time PCR] 8/14(57%) 0/3 eye rinse method 1 13/22(59.1%) 0/3 eye rinse method 1 Authors (year) [PCR type] Yamamoto S et al. (1994) [Conventional PCR] Kudo E et al. (1996) [Nested PCR] Fukuda M, Deai T, et al. (2008) ) [Real-time PCR] Active stromal keratitis Endotheliitis 2/6 (33.33%) *Data are the total no. of subjects with shedding of HSV-1 DNA/total no. of subjects assessed (percentage of patients with shedding of HSV-1 DNA). To evaluate the role of Polymerase Chain Reaction (PCR) in confirmation of diagnosis of clinically suspected Herpetic stromal keratitis or endotheliitis in tear samples To evaluate the effect of antiviral therapy on test result. Inclusion criteria › Clinically diagnosed cases of active stromal keratitis and endotheliitis Exclusion criteria › Pure epithelial keratitis with no stromal involvement › H/o previous oral acyclovir use within one month Study group: 66 eyes( 59 patients) › 52 Unilateral & 7 Bilateral affected Control group: 130 eyes of 90 patients › Contra lateral eye of 50* unilateral affected patients • › Both eyes of 40 normal volunteers *2 patients had contralateral phthisis bulbi and sample from phthisical eye was not taken Before starting treatment, tear samples from both eyes of patients were collected by fire polished microcapillary tube and subjected to PCR for HSV DNA detection PCR Protocol › DNA extraction: commercial QI Amp DNA blood kit › Polymerase chain reaction Primer-111 bp region of HSV 1 thymidine kinase gene (Hofgartner W T et. al Clinical chemistry, 1999) Amplification- thermal cycler (Gene Amp PCR system 9700, applied biosystem, USA) › Electrophoreses- in 2% agarose gel Tab acyclovir 400 mg (5 times/day) × 7 day Tab acyclovir 400 mg (BD) × 6 months Topical steroid (1% prednisolone acetate) Adjunct therapy was given as required Topical antibiotic Topical mydriatic (2% homide) Topical lubricant (preservative free) Analgesics( if required) Follow up examination was done Day 2, day 3-6, day-12, day 13-17, day 18-22 & at 3 mths Repeat PCR was done 3 months after initiating treatment Figure 1: Distribution of tear samples from various clinical categories PUK=Peripheral ulcerative keratitis A= active Q= quiescent P= with perforation V= virus Figure 2: PCR result in different clinical categories PUK=Peripheral ulcerative keratitis A= active Q= quiescent P= with perforation V= virus Figure 3: PCR result in tear samples at presentation and at 3 months FPCR= PCR at follow-up (at 3 month from initiation of treatment) PCR Negative • Necrotizing keratitis with perforation (0/6) • Recurrence in Graft (0/1) • Quiescent stromal keratitis (0/3) Control sample Positive 13 (20%) (Active) • Stromal keratitis 8/30(26%) • Necrotizing keratitis 1/3 (33%) • Keratouveitis 2/11 (22%) • Endotheliitis 2/9 (22%) 20% cases of active Herpetic stromal keratitis and endotheliitis had positive tear sample PCR test result. All positive cases showed good response to treatment and no HSV DNA was detected after antiviral therapy Positive PCR test result can therefore be used as a marker of active viral replication in cases of active stromal keratitis & endotheliitis Address for Correspondence : Professor Radhika Tandon ([email protected]) Dr. RP Centre for Ophthalmic Sciences, AIIMS, New Delhi 110029